MMP24
Basic information
Region (hg38): 20:35226690-35276998
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MMP24 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 38 | 39 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 38 | 2 | 1 |
Variants in MMP24
This is a list of pathogenic ClinVar variants found in the MMP24 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-35226746-G-A | not specified | Uncertain significance (Apr 07, 2023) | ||
20-35226757-G-A | not specified | Uncertain significance (Oct 10, 2023) | ||
20-35226776-C-A | not specified | Uncertain significance (Apr 07, 2023) | ||
20-35226779-C-A | not specified | Uncertain significance (Apr 07, 2023) | ||
20-35226781-C-T | not specified | Likely benign (May 09, 2022) | ||
20-35226791-C-T | not specified | Uncertain significance (Jul 25, 2023) | ||
20-35226803-A-T | not specified | Uncertain significance (Apr 07, 2023) | ||
20-35226830-T-C | not specified | Uncertain significance (Apr 07, 2023) | ||
20-35226842-T-G | not specified | Uncertain significance (Nov 17, 2023) | ||
20-35226878-C-T | not specified | Uncertain significance (Apr 12, 2024) | ||
20-35226886-G-A | not specified | Uncertain significance (Apr 05, 2023) | ||
20-35226886-G-C | not specified | Uncertain significance (Mar 23, 2022) | ||
20-35226892-G-A | not specified | Uncertain significance (Aug 10, 2024) | ||
20-35226956-A-C | not specified | Uncertain significance (Apr 07, 2023) | ||
20-35226961-G-A | not specified | Uncertain significance (Apr 07, 2023) | ||
20-35226962-C-T | not specified | Uncertain significance (Apr 07, 2023) | ||
20-35226977-C-T | not specified | Uncertain significance (Apr 07, 2023) | ||
20-35226979-G-A | not specified | Uncertain significance (Jul 20, 2021) | ||
20-35246862-A-G | not specified | Uncertain significance (Dec 21, 2022) | ||
20-35246882-C-T | not specified | Uncertain significance (Jun 03, 2022) | ||
20-35246892-C-G | not specified | Uncertain significance (Oct 27, 2022) | ||
20-35246910-C-T | not specified | Uncertain significance (Apr 23, 2024) | ||
20-35246955-C-T | not specified | Uncertain significance (Oct 21, 2024) | ||
20-35251922-G-A | not specified | Uncertain significance (Jul 12, 2023) | ||
20-35251961-G-A | not specified | Uncertain significance (Dec 04, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MMP24 | protein_coding | protein_coding | ENST00000246186 | 9 | 50345 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.678 | 0.322 | 125544 | 0 | 9 | 125553 | 0.0000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.28 | 233 | 354 | 0.659 | 0.0000229 | 4142 |
Missense in Polyphen | 89 | 172.55 | 0.51578 | 1821 | ||
Synonymous | 0.796 | 133 | 145 | 0.916 | 0.00000991 | 1311 |
Loss of Function | 3.77 | 5 | 25.6 | 0.195 | 0.00000123 | 308 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000935 | 0.0000913 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000652 | 0.0000616 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Metalloprotease that mediates cleavage of N-cadherin (CDH2) and acts as a regulator of neuro-immune interactions and neural stem cell quiescence. Involved in cell-cell interactions between nociceptive neurites and mast cells, possibly by mediating cleavage of CDH2, thereby acting as a mediator of peripheral thermal nociception and inflammatory hyperalgesia. Key regulator of neural stem cells quiescence by mediating cleavage of CDH2, affecting CDH2-mediated anchorage of neural stem cells to ependymocytes in the adult subependymal zone, leading to modulate their quiescence. May play a role in axonal growth. Able to activate progelatinase A. May also be a proteoglycanase involved in degradation of proteoglycans, such as dermatan sulfate and chondroitin sulfate proteoglycans. Cleaves partially fibronectin, but not collagen type I, nor laminin (By similarity). {ECO:0000250}.;
- Pathway
- Matrix Metalloproteinases;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Degradation of the extracellular matrix
(Consensus)
Recessive Scores
- pRec
- 0.154
Intolerance Scores
- loftool
- 0.472
- rvis_EVS
- -0.62
- rvis_percentile_EVS
- 17.31
Haploinsufficiency Scores
- pHI
- 0.126
- hipred
- Y
- hipred_score
- 0.693
- ghis
- 0.618
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.508
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mmp24
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; cellular phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- proteolysis;glial cell differentiation;extracellular matrix organization;collagen catabolic process;positive regulation of catalytic activity;cell-cell adhesion mediated by cadherin;detection of temperature stimulus involved in sensory perception of pain;neuronal stem cell population maintenance;cell-cell adhesion via plasma-membrane adhesion molecules
- Cellular component
- extracellular space;integral component of plasma membrane;extracellular matrix;trans-Golgi network membrane;extracellular exosome
- Molecular function
- metalloendopeptidase activity;enzyme activator activity;zinc ion binding;cadherin binding